Connect with us
In this final part of a four-part webinar recap, James Graham, Executive Director of Recce Pharmaceuticals (ASX:RCE) presented on the company’s latest announcements and updates, while answering...
In this part three of a four-part webinar recap, Darren Lui, President and Executive Director of Aptorum Group (NASDAQ/EURONEXT:APM) presented on the company’s latest announcements and updates,...
In this part two of a four-part webinar recap, Sean Hall, Chief Executive Officer and Managing Director of Medlab (ASX:MDC) presented on the company’s latest announcements and...
In this one of a four-part webinar recap, Mark Diamond, Managing Director & CEO of Antisense Therapeutics Limited (ASX:ANP) presented on the company’s latest announcements and...
StockPal is hosting its first Biotech & Healthcare webinar on 4 August for four ASX- and NASDAQ-listed health care companies. This webinar is co-organised with Rawson Lewis....
StockPal is hosting its first Biotech & Healthcare webinar for four ASX- and NASDAQ-listed health care companies. Each company is given 15 minutes to present via...
The S&P/ASX 200 Index plunged 1.5 percent as it continues to slide this week. Banks fell across the board as ANZ (ASX:ANZ) dipped 2.1 percent, National...
The S&P/ASX 200 Index managed to edge out 0.6 percent gain as it begins its new financial year.Banking stocks helped the cause as National Australia Bank (ASX:NAB) soared...
Marc Voigt is the Chief Executive Officer of Immutep Limited (ASX:IMM), a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune...
Raffaele (Alfie) Germano is the Chief Executive Officer and Managing Director of Nanollose (ASX:NC6), an Australian based company that has developed technology which can take various...